Outlook Therapeutics Inc (OTLK) concluded trading on Wednesday at a closing price of $1.68, with 0.47 million shares of worth about $0.78 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 13.51% during that period and on June 18, 2025 the price saw a loss of about -0.59%. Currently the company’s common shares owned by public are about 32.91M shares, out of which, 21.22M shares are available for trading.
Stock saw a price change of -6.15% in past 5 days and over the past one month there was a price change of -4.55%. Year-to-date (YTD), OTLK shares are showing a performance of -11.11% which decreased to -78.10% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.87 but also hit the highest price of $9.25 during that period. The average intraday trading volume for Outlook Therapeutics Inc shares is 554.29K. The stock is currently trading -5.02% below its 20-day simple moving average (SMA20), while that difference is up 3.84% for SMA50 and it goes to -43.20% lower than SMA200.
Outlook Therapeutics Inc (NASDAQ: OTLK) currently have 32.91M outstanding shares and institutions hold larger chunk of about 16.68% of that.
The stock has a current market capitalization of $71.99M and its 3Y-monthly beta is at 0.31. It has posted earnings per share of -$1.43 in the same period. It has Quick Ratio of 0.57. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for OTLK, volatility over the week remained 1.83% while standing at 3.54% over the month.
Stock’s fiscal year EPS is expected to rise by 58.87% while it is estimated to increase by 48.95% in next year.
Coverage by BTIG Research stated Outlook Therapeutics Inc (OTLK) stock as a Buy in their note to investors on March 27, 2024, suggesting a price target of $50 for the stock. Stock get an Overweight rating from CapitalOne on December 27, 2023.
